13FLEXICON PHARMACEUTICALS INC (LXRX)
5 tracked managers currently hold LXRX on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | Q2 2026 | ADD | $19.8M | 0.0 % | 0.0 % | 8,251,325 | +436,719 |
| CITADEL ADVISORS LLC | Q2 2026 | ADD | $3.8M | 0.0 % | 0.0 % | 1,601,182 | +506,281 |
| MILLENNIUM MANAGEMENT LLC | Q2 2026 | TRIM | $2.7M | 0.0 % | 0.0 % | 1,134,229 | -3,810,502 |
| TWO SIGMA INVESTMENTS, LP | Q2 2026 | TRIM | $1.5M | 0.0 % | 0.0 % | 643,444 | -556,188 |
| D. E. Shaw & Co., Inc. | Q2 2026 | NEW | $53.3K | 0.0 % | — | 22,200 | NEW |